BRCB · Black Rock Coffee Bar, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on BRCB. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About BRCB · Black Rock Coffee Bar, Inc.
Black Rock Coffee Bar, Inc. owns and operates a chain of drive-thru coffee bars in the United States. It offers classic espresso-based drinks, energy drinks, and savory and sweet items under the all-day breakfast brand. The company was founded in 2008 and is based in Scottsdale, Arizona.
Live Quote
SELL (score -3) · 12-1 mom -76.1% · RSI 42 · below_both · -74.4% from high
Targets blend Wall Street consensus (7 analysts: low $9.00 / mean $17.29 / high $22.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
recent scout:no_anomaly 0.0h ago < cooldown 168h, no material change
BRCB underwent a dramatic -75% price collapse from its 52-week high (~$27.84 in September 2025) to $6.91 — including an ~50% single-session plunge on May 13 after earnings. The stock has fallen through both the IPO price of $20 and its 50-day moving average. The investigation trigger was a Form 4 cluster, but reading each filing reveals these are NOT open-market purchases: all three recent Form 4 filings (Jeff Hernandez, Daniel Brand, Viking Cake BR LLC) filed on May 19 document S-codes — forced selling/disposition of LLC Units and Class C shares as part of a Cynosure equity purchase that triggered margin loan payoff. The only new insider award was an RSU grant to newly hired CDO Jon Vingo (non-purchase). There is no open-market P-code buy among any of the recent filings despite superficial clustering. Fundamentals are challenged: -30% ROIC, 160+ debt-to-equity, EV/EBITDA of 27x on a small-cap restaurant chain trading at near-IPO lows with negative EPS. No upcoming earnings date available from data providers; Q1 results showed +23.7% revenue growth and positive net income for the first time but the stock sold off anyway. Cynosure's acquisition of co-founders' equity ($41.7M) removes a structural overhang — but creates dilution risk via potential future exchanges.